Angiotech and Boston Scientific report good results from Taxus stent tests

VANCOUVER (CP) - Angiotech Pharmaceuticals Inc. and partner Boston Scientific reported good results Wednesday from clinical trials of their Taxus coronary stent systems. Nine-month data from a U.S....More